Atea Pharmaceuticals Participates in the William Blair Biotech Focus Conference Jul 11, 2022 07:00AM
Atea Pharmaceuticals' (AVIR) Continues to Have a Significant Market in COVID Response, Despite Data Setbacks - William Blair Jan 7, 2022 09:45AM
Atea Pharmaceuticals (AVIR) Strong Sell-Off 'Premature' - William Blair Oct 19, 2021 10:55AM
Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference Jul 12, 2021 07:00AM
William Blair Starts Atea Pharmaceuticals (AVIR) at Outperform Nov 24, 2020 06:10AM


Nov 3, 2020 04:01PM Atea Pharmaceuticals Announces Closing of Initial Public Offering
Oct 30, 2020 05:52AM Aviragen Therapeutics (AVIR) Prices 12.5M Share IPO at $24/Sh
Oct 29, 2020 08:00PM Atea Pharmaceuticals Announces Pricing of Initial Public Offering